Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Debra A. Wertz"'
Autor:
Debra A. Wertz, Qing Huang, Liya Wang, Jonathan A. Bernstein, Xuehua Ke, Brandee Paknis, Benjamin Ortiz, Lisa A. Beck, Abhishek Kavati, Vincent J. Willey, Judith J. Stephenson
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 24:598-606
Omalizumab is indicated for the management of chronic idiopathic urticaria (CIU) in patients aged 12 years or older with persistent hives that are not adequately controlled by H1 antihistamines. While its safety and efficacy in CIU patients have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0631614719f4ba7df37ab1bab296b705
https://doi.org/10.18553/jmcp.2018.24.7.598
https://doi.org/10.18553/jmcp.2018.24.7.598
Autor:
Abhishek Kavati, Vincent J. Willey, Judith J. Stephenson, Liya Wang, Debra A. Wertz, Jonathan A. Bernstein, Xuehua Ke, Benjamin Ortiz, Brandee Paknis, Qing Huang, Lisa A. Beck
Publikováno v:
Current Medical Research and Opinion. 34:35-39
To examine treatment patterns, treatment response, and demographic and clinical characteristics of patients with chronic idiopathic urticaria (CIU) newly initiated on omalizumab therapy in real-world practice in the US.This retrospective observationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7233cc5c346e4fe44ce8fdb9a161335
https://doi.org/10.1080/03007995.2017.1395732
https://doi.org/10.1080/03007995.2017.1395732
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Judith J Stephenson,1 Debra Wertz,1 Tao Gu,1 Jeetvan Patel,2 Anand A Dalal2 1HealthCore, Inc., Wilmington, DE, 2GlaxoSmithKline, Research Triangle Park, NC, USA Purpose: The degree to which symptoms such as dyspnea affect patients with COPD is indivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f6891a002df5b05d372f9fdf7fc318
https://doi.org/10.2147/copd.s134618
https://doi.org/10.2147/copd.s134618
Autor:
Tzy-Chyi Yu, Xuehua Ke, David M. Mannino, Judith J. Stephenson, Caroline Geremakis, Jessica Marvel, Liya Wang, Debra A. Wertz
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Xuehua Ke,1 Jessica Marvel,2 Tzy-Chyi Yu,2 Debra Wertz,1 Caroline Geremakis,1 Liya Wang,1 Judith J Stephenson,1 David M Mannino3 1HealthCore Inc., Wilmington, DE, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, 3University of Kentucky, Lexin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::191735382112c97fc9515f9be6357c6f
https://doi.org/10.2147/copd.s108967
https://doi.org/10.2147/copd.s108967
Autor:
Xuehua Ke, Benjamin Ortiz, Qing Huang, Vincent J. Willey, Judith J. Stephenson, Jonathan Corren, Reynold A. Panettieri, Liya Wang, Debra A. Wertz, Abhishek Kavati
Publikováno v:
Clinical therapeutics. 40(7)
The objective of this study was to examine patient characteristics, treatment patterns, and exacerbations among patients with asthma newly treated with omalizumab.Data for this study were obtained from administrative claims and medical records. The i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd4ff591b1e46dc818657b380400ad0d
https://pubmed.ncbi.nlm.nih.gov/30049502
https://pubmed.ncbi.nlm.nih.gov/30049502
Autor:
Elizabeth Marrett, David R. Neff, Dena R. Ramey, Hui-Min Hsieh, Ross J. Simpson, Kaan Tunceli, Terry A. Jacobson, David M. Kern, Joanne E. Tomassini, Judith J. Stephenson, Debra A. Wertz
Publikováno v:
Journal of Clinical Lipidology. 7:399-407
For high-risk patients who do not achieve guideline-recommended LDL-C levels, more intensive treatment including statin-uptitration to higher doses or potency, as well as combination therapy may be considered. A better understanding of statin treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce7c132fa2f744d05db73fd9082ce431
https://doi.org/10.1016/j.jacl.2013.06.002
https://doi.org/10.1016/j.jacl.2013.06.002
Publikováno v:
Current Medical Research and Opinion. 29:773-781
Statin dose, adherence, and cardiovascular (CV) outcomes are important factors when considering switching statin therapies. The objective of the study was to compare CV event rates and risk in managed care patients receiving atorvastatin versus those
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9695ada8d3c92ea574bb98e42b1a344e
https://doi.org/10.1185/03007995.2013.802229
https://doi.org/10.1185/03007995.2013.802229
Autor:
Qing Huang, Xuehua Ke, Benjamin Ortiz, Jonathan Corren, Abhishek Kavati, Debra A. Wertz, Reynold A. Panettieri, Vincent J. Willey, Judith J. Stephenson, Liya Wang
Publikováno v:
Annals of Allergy, Asthma & Immunology. 119:S52-S53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c039dc7e102bba2b435426cdbd0f2252
https://doi.org/10.1016/j.anai.2017.08.249
https://doi.org/10.1016/j.anai.2017.08.249
Autor:
Vincent J. Willey, Mark J. Cziraky, Debra A. Wertz, Rhonda L. Bohn, Chaitanya Sarawate, Chun-Lan Chang
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 3:538-545
Background— This study directly compares risk of acute myocardial infarction (AMI), acute heart failure (AHF), or all-cause death among pioglitazone- and rosiglitazone-treated patients in a managed-care population. Methods and Results— Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aec082116a6f5887c9dd81f584458b5
https://doi.org/10.1161/circoutcomes.109.911461
https://doi.org/10.1161/circoutcomes.109.911461
Publikováno v:
Current Medical Research and Opinion. 25:499-503
To determine the pattern of headache-related resource utilization and costs before and after initiation of preventive migraine treatment with topiramate in a sample of a large managed-care population.This study was a retrospective, longitudinal, coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d0db695f12d1e3895cd9dfc1dfabc3
https://doi.org/10.1185/03007990802664199
https://doi.org/10.1185/03007990802664199